GlassScriptPhysician profile
Robert Edelman
NPI 1649233578
$2,944.45
in general payments reported to CMS, 2019-2025
31 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $367 · 2021: $720 · 2022: $319 · 2023: $149 · 2024: $16.30 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420 · Education: $16.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.90 |
| Education | $16.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $433.42 | 2019-2022 | |
| Boston Scientific Corporation | $396.67 | 2019-2025 | Spaceoar System |
| Neotract INC. | $304.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $238.01 | 2019-2024 | |
| Coloplast Corp | $234.48 | 2019-2025 | Isiris Astent Removal Device, Speedicath |
| Astellas Pharma US INC | $208.56 | 2019-2021 | |
| Pfizer INC. | $151.08 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $139.36 | 2019-2020 | |
| Palette Life Sciences, INC. | $129.71 | 2022 | |
| Blue Earth Diagnostics | $90.45 | 2019-2021 | |
| Civco Medical Instruments | $82.72 | 2025 | |
| Myriad Genetic Laboratories, INC. | $67.59 | 2021 | |
| Allergan, INC. | $52.92 | 2021 | |
| Teleflex LLC | $51.08 | 2021-2023 | Urolift |
| Antares Pharma, INC. | $47.61 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $36.70 | 2022 | |
| Calyxo, INC. | $35.81 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $27.58 | 2022 | |
| Glaxosmithkline, LLC. | $24.08 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.88 | 2020 | |
| Clarus Therapeutics INC. | $23.40 | 2021 | |
| Olympus America INC. | $19.91 | 2025 | Itind System |
| Travere Therapeutics, INC. | $19.03 | 2021 | |
| Dentsply Ih INC. | $18.05 | 2021 | |
| Hollister Incorporated | $17.87 | 2021 | |
| Myovant Sciences INC. | $16.62 | 2021 | |
| Abbvie INC. | $16.44 | 2021 | |
| Laborie Medical Technologies Corp. | $14.77 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $13.93 | 2021 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Edelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.